These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6813097)

  • 1. Developmental localization of noradrenergic innervation to the rat cerebellum following neonatal 6-hydroxydopa and morphine treatment.
    Harston CT; Clark MB; Hardin JC; Kostrzewa RM
    Dev Neurosci; 1982; 5(2-3):252-62. PubMed ID: 6813097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an opioid-specific action of morphine in modifying recovery of neonatally-damaged noradrenergic fibers in rat brain.
    Kostrzewa RM; Klisans-Fuenmayor D
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):3-11. PubMed ID: 6438742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of sprouting and putative regeneration of central noradrenergic fibers by morphine.
    Harston CT; Morrow A; Kostrzewa RM
    Brain Res Bull; 1980; 5(4):421-4. PubMed ID: 7407638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate-enhanced toxicity and noradrenergic sprouting in rats treated with 6-hydroxydopa.
    Harston CT; Clark MB; Hardin JC; Kostrzewa RM
    Eur J Pharmacol; 1981 May; 71(4):365-73. PubMed ID: 6788574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of sprouting of noradrenergic terminals in rat and mouse cerebellum after neonatal 6-hydroxydopa.
    Kostrezewa RM; Klara JW; Robertson J; Walker LC
    Brain Res Bull; 1978; 3(5):525-31. PubMed ID: 122764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in noradrenergic innervation of the brain following dorsal bundle lesions in neonatal rats.
    Klisans-Fuenmayor D; Harston CT; Kostrzewa RM
    Brain Res Bull; 1986 Jan; 16(1):47-54. PubMed ID: 3082466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 6-hydroxydopa on noradrenergic neurons in developing rat brain.
    Kostrzewa RM; Garey RE
    J Pharmacol Exp Ther; 1976 Apr; 197(1):105-18. PubMed ID: 1263125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neonatal 6-hydroxydopa treatment on monamine content of rat brain and peripheral tissues.
    Kostrzewa RM
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):567-79. PubMed ID: 1179028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal Lesioning and Lifelong Effects of the Noradrenergic Neurotoxin 6-Hydroxydopa.
    Kostrzewa RM
    Curr Top Behav Neurosci; 2016; 29():43-50. PubMed ID: 26660536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regenerative critical periods for locus coeruleus in postnatal rat pups following intracisternal 6-hydroxydopamine: a model of noradrenergic development.
    Schmidt RH; Kasik SA; Bhatnagar RK
    Brain Res; 1980 Jun; 191(1):173-90. PubMed ID: 7378749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior.
    Morgan DN; McLean JH; Kostrzewa RM
    Pharmacol Biochem Behav; 1979 Sep; 11(3):309-12. PubMed ID: 504311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracisternal dose-response analysis of 6-hydroxydopamine-induced noradrenergic sprouting in the neonatal rat cerebellum.
    Schmidt RH; Bhatnagar RK
    J Pharmacol Exp Ther; 1980 Mar; 212(3):456-61. PubMed ID: 7359347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal 6-hydroxydopa, but not DSP-4, elevates brainstem monoamines and impairs inhibitory avoidance learning in developing rats.
    Cornwell-Jones CA; Decker MW; Chang JW; Cole B; Goltz KM; Tran T; McGaugh JL
    Brain Res; 1989 Jul; 493(2):258-68. PubMed ID: 2504438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of central noradrenergic system in thyrotropin-releasing hormone-induced behavioral excitement in 6-OHDOPA-treated, infant rats.
    Oki K; Nomura Y; Segawa T
    J Pharmacobiodyn; 1982 Sep; 5(9):716-9. PubMed ID: 6818336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of nerve cell bodies in caudal locus coeruleus following treatment of neonates with 6-hydroxydopa.
    Clark MB; King JC; Kostrzewa RM
    Neurosci Lett; 1979 Aug; 13(3):331-6. PubMed ID: 530483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin conductance activity after intraventricular administration of 6-hydroxydopa in rats.
    Yamamoto K; Hoshino T; Takahashi Y; Kaneko H; Ozawa N
    Biol Psychiatry; 1991 Feb; 29(4):365-75. PubMed ID: 1903660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered histofluorescent pattern of noradrenergic innervation of the cerebellum of the mutant mouse Purkinje cell degeneration.
    Kostrzewa RM; Harston CT
    Neuroscience; 1986 Aug; 18(4):809-15. PubMed ID: 3762927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor.
    Kostrzewa RM; Brus R
    Amino Acids; 1998; 14(1-3):175-9. PubMed ID: 9871458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological evidence for 6-hydroxydopamine-induced sprouting or noradrenergic neurons in the cerebellum.
    Bendeich E; Konkol RJ; Krigman MR; Breese GR
    J Neurol Sci; 1978 Aug; 38(1):47-57. PubMed ID: 702183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different alterations in the development of the noradrenergic innervation of the cerebellum and the brain stem produced by neonatal 6-hydroxydopa.
    Zieher LM; Jaim-Etcheverry G
    Life Sci; 1975 Sep; 17(6):987-91. PubMed ID: 1195992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.